Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Autoliv
ALV
$9.14B
| $1.71M | ﹤0.01% |
23,506
-82,120
| -78% | -$5.83M |
|
|
SFE
1077
DELISTED
Safeguard Scientifics, Inc.
SFE
| $1.71M | ﹤0.01% |
310,246
-431,552
| -58% | -$2.58M |
|
1078
Assured Guaranty
AGO
$3.73B
| $1.7M | ﹤0.01% |
+79,327
| New | +$1.75M |
|
1079
Universal Health Services
UHS
$10.2B
| $1.7M | ﹤0.01% |
15,869
+1,043
| +7% | +$112K |
|
|
ARNA
1080
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.68M | ﹤0.01% |
22,418
+2,303
| +11% | +$154K |
|
1081
Federal Realty Investment Trust
FRT
$10.9B
| $1.67M | ﹤0.01% |
22,774
+4,479
| +24% | +$353K |
|
|
BSX.PRA
1082
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $1.67M | ﹤0.01% |
14,971
| – | – |
|
1083
QuantumScape Corp
QS
$3.05B
| $1.67M | ﹤0.01% |
+99,457
| New | +$1.47M |
|
1084
Hawaiian Electric Industries
HE
$2.26B
| $1.67M | ﹤0.01% |
50,080
-5,394
| -10% | -$189K |
|
1085
Mohawk Industries
MHK
$6.91B
| $1.65M | ﹤0.01% |
16,954
+1,244
| +8% | +$112K |
|
|
KL
1086
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $1.63M | ﹤0.01% |
33,580
-81,734
| -71% | -$4.09M |
|
1087
Lennox International
LII
$15B
| $1.6M | ﹤0.01% |
5,876
+456
| +8% | +$122K |
|
1088
FormFactor
FORM
$6.51B
| $1.6M | ﹤0.01% |
64,066
-1,068
| -2% | -$29.8K |
|
1089
Lear
LEA
$7.39B
| $1.59M | ﹤0.01% |
14,601
+715
| +5% | +$81.5K |
|
1090
NRC Health Common Stock
NRC
$405M
| $1.58M | ﹤0.01% |
32,172
+2,879
| +10% | +$159K |
|
1091
Generac Holdings
GNRC
$11.5B
| $1.57M | ﹤0.01% |
8,134
-919
| -10% | -$151K |
|
1092
Sphere Entertainment
SPHR
$5.02B
| $1.57M | ﹤0.01% |
22,960
-36,889
| -62% | -$2.66M |
|
1093
Sutro Biopharma
STRO
$386M
| $1.57M | ﹤0.01% |
15,602
-709
| -4% | -$67K |
|
|
EBIX
1094
DELISTED
Ebix Inc
EBIX
| $1.56M | ﹤0.01% |
75,882
-5,323
| -7% | -$119K |
|
1095
Ingredion
INGR
$6.42B
| $1.56M | ﹤0.01% |
20,611
-31,930
| -61% | -$2.59M |
|
|
ETNB
1096
DELISTED
89bio
ETNB
| $1.56M | ﹤0.01% |
+60,650
| New | +$1.92M |
|
1097
Lincoln National
LNC
$7.92B
| $1.54M | ﹤0.01% |
49,217
-4,636
| -9% | -$165K |
|
1098
Regency Centers
REG
$14.9B
| $1.54M | ﹤0.01% |
40,403
+2,388
| +6% | +$98.1K |
|
|
SMAR
1099
DELISTED
Smartsheet Inc.
SMAR
| $1.53M | ﹤0.01% |
30,956
+15,612
| +102% | +$754K |
|
1100
Vanguard FTSE Pacific ETF
VPL
$7.77B
| $1.5M | ﹤0.01% |
22,087
+10,319
| +88% | +$689K |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.